Xilio Therapeutics Inc

The current institutional shareholding score of Xilio Therapeutics Inc is 5.00, ranking 132 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 28.99%, representing a quarter-over-quarter decrease of 18.25%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.86% of shares outstanding, with 3.80% increase in holdings.